Hassan Mirzaei

Hassan Mirzaei

Auto-generated profile, based on publicly available information

Hassan Mirzaei

Pharmaceutical Sciences Research Center, Student Research Committee, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2016 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
GHGholamreza Habibi
Gholamreza Habibi
SESaeed Emami
Saeed Emami

1 December 2017 in Bioorganic Chemistry
Verified
Journal Article
Closed access
GHGholamreza Habibi
Gholamreza Habibi
MSMohammad Shokrzadeh
Mohammad Shokrzadeh
MMMona Modanloo
Mona Modanloo
AZAli Ziar
Ali Ziar
GRGholamhossein Riazi
Gholamhossein Riazi
SESaeed Emami
Saeed Emami

1 September 2018 in Journal of Global Antimicrobial Resistance
Verified
Journal Article
Closed access
ASAzar Shokri
Azar Shokri
MAMahdi Abastabar
Mahdi Abastabar
MKMasoud Keighobadi
Masoud Keighobadi
SESaeed Emami
Saeed Emami
Mahdi FakharMahdi Fakhar
Mahdi Fakhar
GHGholamreza Habibi
Gholamreza Habibi

1 April 2019 in Parasitology International
Verified
Journal Article
Closed access
MKMasoud Keighobadi
Masoud Keighobadi
SESaeed Emami
Saeed Emami
Mahdi FakharMahdi Fakhar
Mahdi Fakhar
ASAzar Shokri
Azar Shokri
GHGholamreza Habibi
Gholamreza Habibi
STSaeed Hosseini Teshnizi
Saeed Hosseini Teshnizi

1 October 2009 in Metabolic Syndrome and Related Disorders
Verified
Journal Article
Closed access
GHGholamreza Habibi
Gholamreza Habibi
SASeyed Mohammad Akrami
Seyed Mohammad Akrami
TGTaghi Golmohammadi
Taghi Golmohammadi
MDMahmood Doosti
Mahmood Doosti
RHRamin Heshmat
Ramin Heshmat
PAParvin Amiri
Parvin Amiri
Background: Peroxisome proliferator-activated receptor γ2 (PPARγ2) is a nuclear receptor that regulates adipocyte differentiation, lipid metabolism, and insulin sensitivity. The aim of this study was to investigate the association between the Pro12Ala single nucleotide polymorphism (SNP) at the PPARγ2 gene and type II diabetes (T2DM) and obesity in an Iranian population. Methods: The genomic DNA of the 312 subjects included four groups: (1) nonobese with type II diabetes, (2) obese without type II diabetes, (3) obese with type II diabetes, and (4) nondiabetic nonobese controls. The Pro12Ala polymorphism was detected by polymerase chain reaction–restriction fragment length polymorphism (PCR-RFLP) analysis. Results: Frequencies of the Ala allele in obese subjects were significantly different from those control subjects (odds ratio [OR], 2.358; 95% confidence interval [CI], 1.101–5.05) (P = 0.025). In contrast, no significant association was detected between the Pro12Ala polymorphism and type II diabetes (OR, 0.652; 95% CI, 0.261–1.628). In all subjects, the Ala carriers had a higher body mass index (BMI) compared with the common allele. Conclusions: Our results showed that the Pro12Ala polymorphism in the PPARγ2 gene is associated with obesity in Iranian subjects and the presence of the Ala allele could predict higher BMI.

1 December 2018 in Food Chemistry
Verified
Journal Article
Closed access
SESaeed Emami
Saeed Emami
ZEZahra Esmaili
Zahra Esmaili
GDGholamreza Dehghan
Gholamreza Dehghan
MBMaryam Bahmani
Maryam Bahmani
SHSeyedeh Mahdieh Hashemi
Seyedeh Mahdieh Hashemi
SMSeyyed Ershad Moradi
Seyyed Ershad Moradi